Increasing aging populations and growing hospital infrastructures will drive demand for rheumatoid arthritis drugs.Wilmington ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

Two "key" genes have been identified by scientists linking the painful condition and the bone disease osteoporosis.

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

showed they are “significantly associated” with the progression of both rheumatoid arthritis and osteoporosis. Dr Lo said ...

Predictors of MTX monotherapy treatment success among patients with RA include low disease activity, normal body weight and ESR levels, and fewer tender joints.

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune ...

In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right ...

A breakthrough in Taiwan could mean earlier diagnosis and personalized treatment for those suffering from arthritis and ...

In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), ...

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...

AnaptysBio ( (ANAB) ) has released its Q3 earnings. Here is a breakdown of the information AnaptysBio presented to its investors. AnaptysBio, ...